A detailed history of Azzad Asset Management Inc /Adv transactions in Abbott Laboratories stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 38,917 shares of ABT stock, worth $4.4 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
38,917
Previous 38,686 0.6%
Holding current value
$4.4 Million
Previous $4.4 Billion 8.03%
% of portfolio
0.48%
Previous 0.51%

Shares

54 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$100.73 - $112.44 $23,268 - $25,973
231 Added 0.6%
38,917 $4.04 Billion
Q1 2024

Apr 19, 2024

SELL
$109.52 - $120.96 $9,418 - $10,402
-86 Reduced 0.22%
38,686 $4.4 Billion
Q4 2023

Apr 01, 2024

SELL
$90.19 - $110.4 $1,172 - $1,435
-13 Reduced 0.03%
38,772 $4.27 Billion
Q3 2023

Apr 01, 2024

BUY
$95.53 - $114.62 $764 - $916
8 Added 0.02%
38,785 $3.76 Billion
Q2 2023

Apr 01, 2024

SELL
$100.78 - $112.29 $33,358 - $37,167
-331 Reduced 0.85%
38,777 $4.23 Billion
Q1 2023

Apr 01, 2024

BUY
$96.86 - $114.01 $871 - $1,026
9 Added 0.02%
39,108 $3.96 Billion
Q4 2022

Apr 01, 2024

SELL
$95.06 - $111.52 $3.03 Million - $3.55 Million
-31,855 Reduced 44.9%
39,099 $4.29 Billion
Q3 2022

Apr 01, 2024

BUY
$96.76 - $112.03 $107,500 - $124,465
1,111 Added 1.59%
70,954 $6.69 Billion
Q2 2022

Apr 01, 2024

BUY
$102.07 - $123.37 $3.36 Million - $4.06 Million
32,892 Added 89.02%
69,843 $7.03 Billion
Q1 2022

Apr 01, 2024

BUY
$114.02 - $139.04 $199,535 - $243,320
1,750 Added 4.97%
36,951 $4.37 Billion
Q4 2021

Apr 01, 2024

BUY
$115.53 - $141.46 $117,147 - $143,440
1,014 Added 2.97%
35,201 $4.95 Billion
Q3 2021

Apr 01, 2024

BUY
$116.66 - $129.06 $48,647 - $53,818
417 Added 1.23%
34,187 $4.04 Billion
Q2 2021

Apr 01, 2024

SELL
$105.79 - $124.53 $90,344 - $106,348
-854 Reduced 2.47%
33,770 $3.91 Billion
Q1 2021

Apr 01, 2024

SELL
$108.84 - $128.23 $139,532 - $164,390
-1,282 Reduced 3.57%
34,624 $4.15 Billion
Q4 2020

Apr 01, 2024

BUY
$105.0 - $114.42 $89,880 - $97,943
856 Added 2.44%
35,906 $3.93 Billion
Q3 2020

Apr 01, 2024

BUY
$91.64 - $111.29 $223,418 - $271,325
2,438 Added 7.48%
35,050 $3.81 Billion
Q2 2020

Apr 01, 2024

BUY
$76.57 - $98.0 $882,316 - $1.13 Million
11,523 Added 54.64%
32,612 $2.98 Billion
Q1 2020

Apr 01, 2024

SELL
$62.82 - $91.86 $2.39 Million - $3.49 Million
-37,994 Reduced 64.31%
21,089 $1.66 Billion
Q4 2019

Apr 01, 2024

BUY
$78.51 - $87.4 $84,790 - $94,392
1,080 Added 1.86%
59,083 $5.28 Billion
Q3 2019

Apr 01, 2024

BUY
$81.84 - $88.74 $2.75 Million - $2.98 Million
33,636 Added 138.04%
58,003 $5.11 Billion
Q2 2019

Apr 01, 2024

SELL
$72.88 - $85.0 $45,550 - $53,125
-625 Reduced 2.5%
24,367 $2.05 Billion
Q1 2019

Apr 01, 2024

BUY
$66.22 - $80.06 $69,663 - $84,223
1,052 Added 4.39%
24,992 $2 Billion
Q4 2018

Apr 01, 2024

SELL
$65.56 - $74.27 $234,311 - $265,440
-3,574 Reduced 12.99%
23,940 $1.73 Billion
Q3 2018

Apr 01, 2024

SELL
$60.81 - $73.36 $130,863 - $157,870
-2,152 Reduced 7.25%
27,514 $2.02 Billion
Q2 2018

Apr 01, 2024

BUY
$57.57 - $63.54 $1.71 Million - $1.88 Million
29,666 New
29,666 $1.81 Billion
Q1 2018

Apr 03, 2024

BUY
$56.27 - $63.62 $40,345 - $45,615
717 Added 2.15%
34,111 $2.04 Billion
Q4 2017

Apr 03, 2024

BUY
$53.68 - $57.47 $68,656 - $73,504
1,279 Added 3.98%
33,394 $1.91 Billion
Q3 2017

Apr 03, 2024

BUY
$48.06 - $53.64 $53,875 - $60,130
1,121 Added 3.62%
32,115 $1.71 Billion
Q2 2017

Apr 03, 2024

SELL
N/A
-1,540 Reduced 4.73%
30,994 $1.51 Billion
Q1 2017

Apr 03, 2024

SELL
N/A
-13,090 Reduced 28.69%
32,534 $1.44 Billion
Q4 2016

Apr 03, 2024

BUY
N/A
1,364 Added 3.08%
45,624 $1.75 Billion
Q3 2016

Apr 03, 2024

BUY
N/A
1,582 Added 3.71%
44,260 $1.87 Billion
Q2 2016

Apr 03, 2024

BUY
N/A
2,393 Added 5.94%
42,678 $1.68 Billion
Q1 2016

Apr 03, 2024

BUY
N/A
3,142 Added 8.46%
40,285 $1.69 Billion
Q4 2015

Apr 03, 2024

BUY
N/A
5,589 Added 17.71%
37,143 $1.67 Billion
Q3 2015

Apr 03, 2024

BUY
N/A
4,385 Added 16.14%
31,554 $1.3 Billion
Q2 2015

Apr 03, 2024

SELL
N/A
-3,620 Reduced 11.76%
27,169 $1.33 Billion
Q1 2015

Apr 03, 2024

BUY
N/A
10,701 Added 53.27%
30,789 $1.43 Billion
Q4 2014

Apr 03, 2024

BUY
N/A
2,085 Added 11.58%
20,088 $904 Million
Q3 2014

Apr 03, 2024

BUY
N/A
764 Added 4.43%
18,003 $749 Million
Q2 2014

Apr 03, 2024

BUY
N/A
3,213 Added 22.91%
17,239 $705 Million
Q1 2014

Apr 03, 2024

BUY
N/A
2,209 Added 18.69%
14,026 $540 Million
Q4 2013

Apr 03, 2024

BUY
N/A
840 Added 7.65%
11,817 $453 Million
Q2 2013

Apr 03, 2024

SELL
N/A
-7,028 Reduced 39.03%
10,977 $368 Million
Q1 2013

Apr 03, 2024

SELL
N/A
-20,767 Reduced 53.56%
18,005 $636 Million
Q4 2012

Apr 08, 2024

SELL
N/A
-578 Reduced 4.18%
13,251 $868 Million
Q3 2012

Apr 08, 2024

SELL
N/A
-4,457 Reduced 24.37%
13,829 $948 Million
Q2 2012

Apr 08, 2024

BUY
N/A
3,399 Added 22.83%
18,286 $1.18 Billion
Q1 2012

Apr 08, 2024

SELL
N/A
-1,429 Reduced 8.76%
14,887 $912 Million
Q4 2011

Apr 08, 2024

BUY
N/A
543 Added 3.44%
16,316 $917 Million
Q3 2011

Apr 08, 2024

BUY
N/A
3,256 Added 26.01%
15,773 $807 Million
Q2 2011

Apr 08, 2024

BUY
N/A
4,973 Added 65.92%
12,517 $659 Million
Q1 2011

Apr 08, 2024

SELL
N/A
-699 Reduced 8.48%
7,544 $370 Million
Q4 2010

Apr 08, 2024

SELL
N/A
-30,529
8,243 $395 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.